Tredje AP fonden lifted its stake in Michaels Companies (NASDAQ:MIK) by 68.1% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 34,680 shares of the specialty retailer’s stock after acquiring an additio
HDFC Securities' research report on Jubilant Life Sciences
Unlike in 3QFY18, when only LSI segment led the top line growth, 4QFY18 performance of 41%YoY growth was fueled by both the key segments (Pharma: 53%YoY, LSI: 24%YoY). Adjusted for Triad, the top-line grew ~21%YoY. EBITDA
This is part of a series of stories that comprise TheStreet’s Blue Chip Studio, which will illuminate issues related to corporate board performance, activism, dealmakers and personalities revealed by analysis of data generated by BoardEx, a business unit of TheStreet.
BlackRock (BLK), the world’s largest asset manager, said it will be putting pressure on companies to address boardroom....More>>>
Warren Buffett-led Berkshire Hathaway stock could provide similar diversification as S&P 500 ETF with even better results.
Many investors prefer a diversified low-risk portfolio over theriskier strategy of stock-picking. The SPDR S&P 500 ETF Trust (NYSEMKT:SPY) is very popular for this purpose since it follows the S&P 500 index of 500 large cap companies listed on the NYSE....More>>>
One of the joys of investing in stocks is watching dividend payments roll in quarter after quarter. Giant capital gains from growth stocks may be more exciting, but a reliable and growing stream of dividend payments, reinvested in more stocks, unleashes the true power of compounding. Dividends have accounted for nearly half of the total return of the S&P 500 Index over the past 25 years. You....More>>>
Welcome. In this article I will give the dollar and cents reasons for how come ERIC looks like a relative bargain in today’s marketplace.
In the trailing ten years ERIC has earned their market cap in free cash flow. This is a signal the company may be undervalued. If ERIC can repeat the performance and earn over $19B in the coming....More>>>
My favorite discovery in the field of behavioral economics confirms what we already knew deep down, even if it contradicts “common sense”–that experiences are more valuable than stuff. I recently put this finding to the test:
Concert of a Lifetime
Those were my wife’s words when I called her from the road, rushing to....More>>>
Shares of Tesaro (TSRO) are soaring today after the biotech company reported positive data for its treatment of ovarian cancer over the weekend. Credit Suisse analyst Alethia Young and team contend that “M&A remains in focus” for Tesaro following the data:
We are increasing our target price to $122 from $90 as we move to an M&A DCF valuation.....More>>>
Synchrony Financial (NYSE:SYF) is trading at a PE for 2018 of 10.6x with a yield of 1.7%. The business is growing well organically and has abundant capital. All this gives you three reasons to own SYF: nice value, growth and capital return (which might segue into a boost to growth).
Let’s start with the capital: CET1 ratio of nearly 18% at 3Q16 on a Basel III fully phased in basis.....More>>>
JPMorgan’s Ken Goldman and Joshua Levine explain why they’re refusing to follow at least six of their fellow analysts and cut their rating on Hain Celestial Group (HAIN) after the natural-products company said it had to delay the release of its earnings due to accounting irregularities:
Hain Celestial products Hain Celestial
Yesterday after the close, Hain Celestial....More>>>
Are you an investor interested in learning more about Vitality Biopharma Inc (OTCMKTS:VBIO)? Or, are you looking to take your first look at VBIO? A SeeThruEquity research report posted in August not only has you covered, it underscores all of its hidden bullishness. The report also explains a very impressive target price for Vitality Biopharma shares. In short, the research outfit now believes the....More>>>
Allianz (FRA:ALV) has been assigned a €217.00 ($258.33) price objective by JPMorgan Chase in a research note issued on Monday. The firm currently has a “neutral” rating on the stock. JPMorgan Chase’s price objective indicates a potential upside of 13.32% from the stock
Doliver Capital Advisors LP increased its holdings in shares of Ishares S&P 500 (NYSEARCA:IVV) by 2.7% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 32,234 shares of the company’s stock after acquiring an a
Shares of ASOS.com (LON:ASC) have earned a consensus recommendation of “Buy” from the twenty ratings firms that are currently covering the stock, MarketBeat reports. Three investment analysts have rated the stock with a sell recommendation, three have assigned a hold recommendation